Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Rahimi, Kaveh ()
  • Source:
    Neurological Sciences. Nov2020, Vol. 41 Issue 11, p3149-3156. 8p. 3 Charts.
  • Additional Information
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      Similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), the coronavirus disease 2019 (COVID-19) has neurological symptoms. COVID-19 patients have such clinical symptoms as headache, vomiting, nausea, dizziness, myalgia, anosmia, ageusia, and disorder of consciousness. These symptoms confirm that the nervous system is involved in the COVID-19 infection. Guillain-Barré syndrome (GBS) is a heterogeneous disorder which often follows a viral infection. According to the assessment case reports from the beginning of the COVID-19 infection so far, it is possible that GBS is linked to the COVID-19 infection. It seems that paying attention to the neurological effects of COVID-19 is necessary. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)